Login

David Richards, CEO of WANdisco PLC, recently discussed his company's approach to simplifying cloud technology.|David Richards, CEO of WANdisco PLC 00:10:00

Share On Facebook Share On Twitter

David Richards, CEO of WANdisco PLC

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
BBVA's Successful Year: Growth, Profitability, and Societal Impact | Carlos Torres Vila , President , BBVA .
00:10:00
Dedicated Advisors and Service Team to Achieve Your Financial Goals
00:10:00
Sequoia India operates in Southeast Asia and India where we actively partner with founders from a wide range of companies|Sakshi Chopra,Managing Director,Sequoia Capital India
00:10:00
Alex Kimber on Building Client-Focused Careers at Lord Abbett
00:10:00
Interview with Sean Vokes, CEO of Talisman Mining on Assay TV
00:10:00
First Cobalt Corp: Cobalt Refinery and Exploration Focus
00:10:00
Hartford CEO Christopher J. Swifton Economic Outlook, Inflation, and California's Regulatory Challenges | Christopher J. Swift, CEO , The Hartford.
00:10:00
Join us for an engaging podcast episode featuring Renaud de Viel Castel, COO and Head of Global Expansion at Rubicon Technologies, Inc.
00:10:00
Ensuring Competency and Safety at Cooper Equipment
00:10:00
Tanzanian Gold: Resource and Production Growth Presentation
00:10:00
ROCA Industry’s Strong First Semester Results and Market Outlook | Ionuț Bindea, CEO, ROCA Industry Holdingrock1 SA.
00:10:00
How has the market impacted investment & CISO buying strategies|Yoav Andrew Leitersdorf,Managing Partner,YL Ventures

© 2017 - Neuhu+